{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:41Z","timestamp":1793032841888,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100660","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:46:39Z","timestamp":1788950799000},"page":"100660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tip-retained hydrated silk fibroin microneedles for sustained local delivery of TNF-\u03b1 antagonist in psoriasis treatment"],"prefix":"10.1016","volume":"12","author":[{"given":"Sai","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100660_bb0005","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpx.2026.100660_bb0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijpx.2026.100660_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100660_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2005.12.009","article-title":"Silk fibroin as an organic polymer for controlled drug delivery","volume":"111","author":"Hofmann","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100660_bb0025","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1021\/bm200062a","article-title":"Regulation of silk material structure by temperature-controlled water vapor annealing","volume":"12","author":"Hu","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpx.2026.100660_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.109842","article-title":"Tuning the conformation and mechanical properties of silk fibroin hydrogels","volume":"134","author":"Johari","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ijpx.2026.100660_bb0035","doi-asserted-by":"crossref","first-page":"773","DOI":"10.36849\/jdd.7411","article-title":"Psoriasis and skin barrier dysfunction: the role of gentle cleansers and moisturizers in treating psoriasis","volume":"22","author":"Kircik","year":"2023","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ijpx.2026.100660_bb0040","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1016\/j.xphs.2016.07.008","article-title":"Tip-loaded dissolvable microneedle arrays effectively deliver polymer-conjugated antibody inhibitors of tumor-necrosis-factor-alpha into human skin","volume":"105","author":"Korkmaz","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100660_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/2475530318810851","article-title":"TNF inhibitor-induced psoriasis: proposed algorithm for treatment and management","volume":"4","author":"Li","year":"2019","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"10.1016\/j.ijpx.2026.100660_bb0050","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.biopha.2018.10.062","article-title":"Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-\u03baB and TLR7 pathways in mice","volume":"109","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100660_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13329","article-title":"Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway","volume":"29","author":"Li","year":"2023","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ijpx.2026.100660_bb0060","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1177\/1535370216647183","article-title":"Original research: different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models","volume":"241","author":"Luo","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ijpx.2026.100660_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122207","article-title":"Tacrolimus nanocrystals microneedle patch for plaque psoriasis","volume":"627","author":"Men","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100660_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100660_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd1304","article-title":"Current status and future potential of transdermal drug delivery","volume":"3","author":"Prausnitz","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100660_bb0080","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","article-title":"Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems","volume":"25","author":"Rapalli","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpx.2026.100660_bb0085","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/nprot.2011.379","article-title":"Materials fabrication from Bombyx mori silk fibroin","volume":"6","author":"Rockwood","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpx.2026.100660_bb0090","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1038\/sj.onc.1207915","article-title":"TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?","volume":"23","author":"Scott","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ijpx.2026.100660_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40257-013-0053-5","article-title":"Safety and tolerability of tumor necrosis factor-\u03b1 inhibitors in psoriasis: a narrative review","volume":"15","author":"Semble","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ijpx.2026.100660_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis\u2014current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ijpx.2026.100660_bb0105","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpx.2026.100660_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00063030-200519010-00006","article-title":"TNF\u03b1 inhibitors in the treatment of psoriasis and psoriatic arthritis","volume":"19","author":"Tobin","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijpx.2026.100660_bb0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/pharmaceutics11100494","article-title":"Silk fibroin as a functional biomaterial for drug and gene delivery","volume":"11","author":"Tomeh","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100660_bb0120","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpx.2026.100660_bb0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2013.05.005","article-title":"Microneedles for intradermal and transdermal drug delivery","volume":"50","author":"Tuan-Mahmood","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100660_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125073","article-title":"Self-assembled hyaluronic acid nanoparticles delivered by polymeric microneedles for targeted and long-acting therapy of psoriasis","volume":"669","author":"Zeng","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100660_bb0135","article-title":"Microneedle-based sustained release delivery of TNF-\u03b1\/IL-6R dual-specific fenobody alleviates inflammation and promotes bone regeneration in rheumatoid arthritis rat model","volume":"33","author":"Zhang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ijpx.2026.100660_bb0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s44222-023-00141-6","article-title":"Microneedle biomedical devices","volume":"2","author":"Zheng","year":"2024","journal-title":"Nat. Rev. Bioeng."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:12:45Z","timestamp":1793031165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S2590156726001805"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100660","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tip-retained hydrated silk fibroin microneedles for sustained local delivery of TNF-\u03b1 antagonist in psoriasis treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100660"}}